EF
VIR icon

Empowered Funds’s Vir Biotechnology VIR Stock Holding History

Empowered Funds’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$267K Sell
29,837
-1,029
-3% -$8.2K ﹤0.01% 1876
2025
Q4 		$186K Buy
30,866
+841
+3% +$5.01K ﹤0.01% 944
2025
Q3 		$171K Sell
30,025
-232
-0.8% -$1.19K ﹤0.01% 1745
2025
Q2 		$152K Sell
30,257
-1,499
-5% -$8.04K ﹤0.01% 1677
2025
Q1 		$206K Sell
31,756
-258,870
-89% -$2.3M ﹤0.01% 1503
2024
Q4 		$2.13M Sell
290,626
-39,155
-12% -$309K 0.03% 710
2024
Q3 		$2.47M Sell
329,781
-163,723
-33% -$1.42M 0.04% 590
2024
Q2 		$4.39M Buy
493,504
+35,460
+8% +$340K 0.08% 363
2024
Q1 		$4.64M Buy
458,044
+34,640
+8% +$353K 0.08% 333
2023
Q4 		$4.26M Buy
423,404
+38,269
+10% +$350K 0.11% 278
2023
Q3 		$3.61M Buy
+385,135
New +$5.49M 0.11% 257

Other funds holding VIR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return